18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin’s lymphoma
Open Access
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (1), 29-37
- https://doi.org/10.1023/a:1008357126404
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Computertomographie und F-18-FDG-Positronen-Emissions-Tomographie im Staging maligner Lymphome: ein VergleichRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1998
- 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.Journal of Clinical Oncology, 1998
- Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.Radiology, 1997
- Staging of Burkitt's lymphoma and response to treatment monitored by pet scanningClinical Oncology, 1995
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- [18F]Fluorodeoxyglucose Uptake in TumorsJournal of Computer Assisted Tomography, 1993
- Gallium 67 imaging in monitoring lymphoma response to treatmentCancer, 1988
- The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.Journal of Clinical Oncology, 1988
- Reporting results of cancer treatmentCancer, 1981
- Normal erythrocyte sedimentation rate and age.BMJ, 1967